These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35242816)
41. A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties. Schanzer JM; Wartha K; Croasdale R; Moser S; Künkele KP; Ries C; Scheuer W; Duerr H; Pompiati S; Pollman J; Stracke J; Lau W; Ries S; Brinkmann U; Klein C; Umana P J Biol Chem; 2014 Jul; 289(27):18693-706. PubMed ID: 24841203 [TBL] [Abstract][Full Text] [Related]
42. A HER2 bispecific antibody can be efficiently expressed in Lin L; Li L; Zhou C; Li J; Liu J; Shu R; Dong B; Li Q; Wang Z Oncol Lett; 2018 Jul; 16(1):1259-1266. PubMed ID: 29963199 [TBL] [Abstract][Full Text] [Related]
43. Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species-mediated therapies. Park CG; Lee W; Kim DH; Li F; Park W Front Mol Biosci; 2022; 9():1046852. PubMed ID: 36310599 [TBL] [Abstract][Full Text] [Related]
44. Corrigendum: Isoform Age - Splice Isoform Profiling Using Long-Read Technologies. De Paoli-Iseppi R; Gleeson J; Clark MB Front Mol Biosci; 2021; 8():767743. PubMed ID: 34646863 [TBL] [Abstract][Full Text] [Related]
45. Corrigendum: A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke. Eyford BA; Singh CSB; Abraham T; Munro L; Choi KB; Hill T; Hildebrandt R; Welch I; Vitalis TZ; Gabathuler R; Gordon JA; Adomat H; Guns EST; Lu CJ; Pfeifer CG; Tian MM; Jefferies WA Front Mol Biosci; 2021; 8():687587. PubMed ID: 34026851 [TBL] [Abstract][Full Text] [Related]
47. Corrigendum: From adhesion complex to signaling hub: the dual role of dystroglycan. Sciandra F; Bozzi M; Bigotti MG Front Mol Biosci; 2024; 11():1388846. PubMed ID: 38562555 [TBL] [Abstract][Full Text] [Related]
49. Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib. Zhang L; Yan ZP; Hou ZH; Huang P; Yang MJ; Zhang S; Zhang S; Zhang SH; Zhu XL; Ni CF; Li Q Front Mol Biosci; 2021; 8():727969. PubMed ID: 34527705 [TBL] [Abstract][Full Text] [Related]
50. Corrigendum: Swimming attenuates muscle wasting and mediates multiple signaling pathways and metabolites in CT-26 bearing mice. Li J; Xie Q; Liu L; Cheng Y; Han Y; Chen X; Lin J; Li Z; Liu H; Zhang X; Chen H; Peng J; Shen A Front Mol Biosci; 2022; 9():1005797. PubMed ID: 36120539 [TBL] [Abstract][Full Text] [Related]
51. Corrigendum: Systematic analysis of MCM3 in pediatric medulloblastoma Cao L; Zhao Y; Liang Z; Yang J; Wang J; Tian S; Wang Q; Wang B; Zhao H; Jiang F; Ma J Front Mol Biosci; 2022; 9():1076243. PubMed ID: 36452454 [TBL] [Abstract][Full Text] [Related]
52. Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer. Gan J; Meng Q; Li Y Front Mol Biosci; 2021; 8():653454. PubMed ID: 33928124 [TBL] [Abstract][Full Text] [Related]
53. Corrigendum: Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins. Ha JH; Kim JE; Kim YS Front Immunol; 2017; 8():1582. PubMed ID: 29151837 [TBL] [Abstract][Full Text] [Related]
55. Generation of orthogonal Fab-based trispecific antibody formats. Wu X; Yuan R; Bacica M; Demarest SJ Protein Eng Des Sel; 2018 Jul; 31(7-8):249-256. PubMed ID: 29718394 [TBL] [Abstract][Full Text] [Related]
56. Corrigendum: CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study. Huang X; Liu W; Liu C; Hu J; Wang B; Ren A; Huang X; Yuan Y; Liu J; Li M Front Mol Biosci; 2024; 11():1452740. PubMed ID: 39108342 [TBL] [Abstract][Full Text] [Related]
57. Corrigendum: Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling. Zhuang C; Liu Y; Fu S; Yuan C; Luo J; Huang X; Yang W; Xie W; Zhuang C Front Mol Biosci; 2021; 8():664616. PubMed ID: 34631791 [TBL] [Abstract][Full Text] [Related]
58. Corrigendum to: Development of bispecific antibodies in China: overview and prospects. Zhang J; Yi J; Zhou P Antib Ther; 2022 Jan; 5(1):84. PubMed ID: 35372785 [TBL] [Abstract][Full Text] [Related]
59. Corrigendum: Self-assembling and pH-Responsive protein nanoparticle as potential platform for targeted tumor therapy. Xu Z; Zhang X; Dong W; Lv H; Zuo L; Zhu L; Wang R; Ma X Front Mol Biosci; 2023; 10():1232803. PubMed ID: 37426422 [TBL] [Abstract][Full Text] [Related]
60. Diabody-based recombinant formats of humanized IgG-like bispecific antibody with effective retargeting of lymphocytes to tumor cells. Asano R; Kawaguchi H; Watanabe Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I J Immunother; 2008 Oct; 31(8):752-61. PubMed ID: 18779744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]